Presentation NY Valves 2024 Direct Oral Anticoagulants Versus Vitamin K Antagonists After TAVR Presenter: Agam Bansal June 06, 2024
Presentation TVT 2023 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis Presenter: Mustafa Suppah June 08, 2023
Presentation TCT 2022 TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis Presenter: Khawaja Akhtar September 19, 2022
Presentation TCT 2022 TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis Presenter: Davide Cao September 18, 2022
Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016
Presentation TCT 2013 Chelation Therapy and High Dose Vitamin Therapy: Results and Perspectives on the Controversy Presenter: Gervasio Lamas October 27, 2013